Skip to content

Privia Health

US · PRVA #2604 by market cap Listed 2021
25.05 +0.36 +1.46%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 4 in the most recent period (2026/Q3).
  • Total institutional ownership fell 2.4 percentage points.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
98.10% -2.43pp
Institutions
366 +4
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund71.37%
Hedge Fund14.26%
VC/PE Fund6.10%
Public Company2.35%
Insurance Company2.22%
Government Pension Fund1.24%
Individual/Insider0.49%
Private Company0.47%
Other1.47%

Top holders as of 2026-09-30

BlackRock 17.73% · 22.65M sh
Durable Capital Partners, LP 9.11% · 11.64M sh
FMR 5.34% · 6.82M sh
Vanguard Portfolio Management, LLC 5.32% · 6.79M sh
Rubicon Founders LLC 5.07% · 6.47M sh
Vanguard Capital Management, LLC 4.34% · 5.54M sh
State Street Global Advisors 4.03% · 5.15M sh
Van Berkom and Associates Inc. 2.88% · 3.69M sh
Geode Capital Management, LLC 2.51% · 3.20M sh
Riverbridge Partners, LLC 2.27% · 2.90M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 12 buys · 38 sells

NameRoleStake
David Mountcastle Chief Financial Officer 0.14%
Parth Mehrotra Chief Executive Officer 0.11%
Matthew Morris Former Director 0.07%
Thomas McCarthy Independent Director 0.05%
David King Independent Chairperson 0.03%
Jaewon Ryu Independent Director 0.03%
Nancy Cocozza Independent Director 0.03%
Pamela Kimmet Independent Director 0.02%
David Wichmann Former Independent Director 0.01%
Edward Fargis Executive VP, General Counsel, Chief Legal Officer & Corporate Secretary 0.01%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-08-31 Opella Ernest Director Other Acquisition +6,350 --
2026-07-08 David Mountcastle Chief Financial Officer Automatic Disposition -21,275 $27.67
2026-07-06 David Mountcastle Chief Financial Officer Automatic Disposition -600 $27.57
2026-07-05 Matthew Morris Former Director Derivative Exercise and Sale -112,759 $2.00–27.33
2026-07-01 David Mountcastle Chief Financial Officer Automatic Disposition -24,734 $27.50
2026-06-30 Matthew Morris Former Director Derivative Exercise and Sale -135,498 $2.00–26.93
2026-06-28 Matthew Morris Former Director Derivative Exercise and Sale -151,322 $2.00–25.33
2026-06-25 David Mountcastle Chief Financial Officer Derivative Exercise and Sale -17,196 $2.00–25.18
2026-05-19 Francis Soistman Independent Director Other Acquisition +8,463 --
2026-05-19 Lance Berberian Independent Director Other Acquisition +8,463 --
2026-05-19 Nancy Cocozza Independent Director Other Acquisition +8,463 --
2026-05-19 David King Independent Chairperson Other Acquisition +8,463 --
2026-05-19 Pamela Kimmet Independent Director Other Acquisition +8,463 --
2026-05-19 Matthew Morris Former Director Other Acquisition +8,463 --
2026-05-19 Thomas McCarthy Independent Director Other Acquisition +8,463 --
2026-05-19 Jaewon Ryu Independent Director Other Acquisition +8,463 --
2026-05-11 Parth Mehrotra Chief Executive Officer Open Market Disposition -121,086 $22.55–22.64
2026-05-11 Parth Mehrotra Chief Executive Officer Intent to Sell (Form 144) -15,647 $22.64
2026-05-10 David Mountcastle Chief Financial Officer Open Market Disposition -3,385 $22.60
2026-05-10 Parth Mehrotra Chief Executive Officer Intent to Sell (Form 144) -91,403 $22.55

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.

Privia Health discussion 0 comments

Add a comment